A World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety.
“This is what we want to see with trials, it is a well-run trial. Safety is always critical, it is crucial and they have looked at that in an appropriate manner,” Margaret Harris told journalists in Geneva.
Asked to react to experimental COVID-19 vaccine use in China and Russia, she said: “The WHO would like to see vaccines go head to head so we can have clear information and to see these results against each other.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportU.S. trials of AstraZeneca Plc.'s undefined and Oxford University COVID-19 vaccine candidate will be on hold until at least midweek, pending a Federal Drug...
Read more »
AstraZeneca COVID-19 vaccine trials resume in BrazilClinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative...
Read more »
Vaccine maker got $1 billion from taxpayers. Now it's boosting drug pricesOne of the world’s largest drug companies has been aggressively raising prices even as it received hundreds of millions of dollars of U.S. government aid to develop a COVID-19 vaccine.
Read more »
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Read more »
When will there be a COVID-19 vaccine and should you trust that it's safe?Americans want a COVID-19 vaccine—but worry that it could be rushed out before the election. Here's what the science says.
Read more »
Stocks jump at the open on vaccine, merger newsU.S. stocks opened higher Monday, buoyed by deal-making and prospects for a COVID-19 vaccine. The Dow Jones Industrial Average undefined rose 192 points,...
Read more »